Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Unspecified Adult Solid Tumor - Protocol Specific|Breast Cancer - Female
Interventions: DRUG: Pazopanib|DRUG: Paclitaxel|DRUG: Carboplatin
Sponsor: Rutgers, The State University of New Jersey
Collaborators: National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey|GlaxoSmithKline